Similar articles

• The systemic-onset variant of juvenile idiopathic arthritis needs to be recorded as an autoinflammatory syndrome: comment on the review by Nigrovic.

  Rigante D, Cantarini L. Rigante D, et al. Arthritis Rheumatol. 2014 Sep;66(9):2645. doi: 10.1002/art.38698. Arthritis Rheumatol. 2014. PMID: 24839178 No abstract available.
• Review: is there a window of opportunity for treatment of systemic juvenile idiopathic arthritis?

  Nigrovic PA. Nigrovic PA. Arthritis Rheumatol. 2014 Jun;66(6):1405-13. doi: 10.1002/art.38615. Arthritis Rheumatol. 2014. PMID: 24623686 Review. No abstract available.
• [Anakinra treatment in refractory systemic onset juvenile arthritis].

  Garrido Colino C, Saavedra Lozano J. Garrido Colino C, et al. An Pediatr (Barc). 2008 Mar;68(3):305-6. doi: 10.1157/13116717. An Pediatr (Barc). 2008. PMID: 18358148 Spanish. No abstract available.
• Reverse Translation in Advancing Pharmacotherapy in Pediatric Rheumatology: A Logical Approach in Rare Diseases with Limited Resources.

  Becker ML, Funk RS. Becker ML, et al. Clin Transl Sci. 2018 Mar;11(2):106-108. doi: 10.1111/cts.12513. Epub 2017 Nov 28. Clin Transl Sci. 2018. PMID: 29193724 Free PMC article. No abstract available.
• Juvenile idiopathic arthritis: therapies in the 21st century.

  Haines KA. Haines KA. Bull NYU Hosp Jt Dis. 2007;65(3):205-11. Bull NYU Hosp Jt Dis. 2007. PMID: 17922671 Review.